Michigan Heart is a leader in comprehensive cardiovascular care - setting the standard for excellence, providing the highest quality care with outstanding results by promoting the most professional, thorough and cost-conscious approach to patient care. Affiliated with trusted and renowned hospital systems, Michigan Heart has been serving the community for over forty years and is recognized, respected and sought on a national level. Headquartered in Ann Arbor with eight locations serving Southeast Michigan, we are led by dedicated and talented physicians who offer a broad range of expertise covering all of the subspecialties of cardiovascular medicine. Together with our motivated and enthusiastic staff, Michigan Heart is united in providing care as if each patient, referring physician, community member or fellow professional were a valued family member. As a result of strong leadership, dedication to service and mutual respect, Michigan Heart supports and nurtures personal and professional growth and development of our staff through comprehensive orientation, ongoing training and advancement opportunities. The enriching environment of Michigan Heart promotes positive "Can Do!" attitudes that translate directly into our patient care philosophy.
| Contact Details: |
| 1548 W. Maumee Street, Suite C |
| Adrian |
| Michigan |
| 49221 |
| United States of America |
| Tel: | (517) 266-1042 |
| Fax: | (517) 266-1344 |
| Email: | |
| WWW: | www.MICHIGANHEART.COM/

|
|
Loading...
|
Recent Publications by Michigan Heart: |  |
Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol.
Since generic simvastatin became available in the United States in 2006,... | 23rd September, 2009
| 1Clinical Scholars Program, Michigan Heart and Vascular Institute at St.
| Am J Ther. 2009 Sep 15.
DOI Direct Link |
Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan.
BACKGROUND: Although statins are widely used for the prevention and... | 15th April, 2009
| Clinical Scholars Program, Michigan Heart & Vascular Institute at St.
| Curr Med Res Opin. 2009 Jan;25(1):205-13.
DOI Direct Link |
Peripheral arterial disease in the elderly: recognition and management.
Peripheral arterial disease (PAD) is a common but frequently overlooked... | 14th April, 2009
| Clinical Scholars Program, Michigan Heart & Vascular Institute, St Joseph
| Am J Cardiovasc Drugs. 2008;8(6):353-64. doi:
|
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
BACKGROUND: The optimal duration of dual antiplatelet therapy after... | 25th February, 2009
| Clinical Scholars Program, Michigan Heart and Vascular Institute at St.
| Am Heart J. 2009 Feb;157(2):369-74. Epub 2008 Nov 1.
DOI Direct Link |
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.
Animal experimental data have shown that lipid-lowering agents reduce... | 7th January, 2009
| Clinical Scholars Program, Michigan Heart and Vascular Institute at St.
| Am J Cardiol. 2008 Nov 1;102(9):1119-24. Epub 2008 Aug 27.
DOI Direct Link |
→View more Michigan Heart research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 249 times since April 2007, the link to the organisation's website has been followed 35 times
Search for more companies in Adrian
Search for more companies in Michigan
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Michigan Heart